For further validation, we knocked down GSDME expression in 786‐O and A‐498 cells and found that it increased the resistance of renal cancer cells to the combined toxicity of SGI‐1027 and everolimus (Figure S7D–F, Supporting Information). The gene discussed is GSDME; the disease is renal carcinoma.